Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2 1

Status

Completed 17Recruiting 7Terminated 5Unknown 4Withdrawn 3Active not recruiting 3

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Genitourinary 2Lymphoid 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Prostatic Neoplasms 1Prostate Adenocarcinoma 1Lymphoma, Follicular 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Drug Therapy 219Cyclophosphamide 219Paclitaxel 205apatinib 201Bevacizumab 196camrelizumab 190Fluorouracil 188sintilimab 133Irinotecan 125Blood Specimen Collection 125Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 112Pemetrexed 108anlotinib 105S 1 (combination) 105Leucovorin 102Surveys and Questionnaires 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × OTHER × fluciclovine F-18 × Clear all
NCT03762759 2024-05-17

Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes

Emory University

Phase 2 Unknown
140 enrolled
Genitourinary

Prostate Adenocarcinoma

NCT05479136 2022-10-27

DRARCH

St. Joseph's Hospital and Medical Center, Phoenix

Phase 3 Unknown
30 enrolled
Lymphoid

Lymphoma, Follicular

NCT03349463 2020-02-28

Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers.

Loyola University

Phase 4 Unknown
30 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT03996993 2019-06-25

Defining Recurrent Disease With Axuminâ„¢

Cancer Center of Irvine

Unknown
20 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡